Cyno EpCAM Lentivirus

Catalog #
78978
$975 *
Size: 500 µl x 2
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Cyno EpCAM Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. These particles transduce cynomolgus monkey (Macaca fascicularis) EpCAM (epithelial cell adhesion molecule; XM_045369368.1) driven by an EF1A promoter, and a puromycin selection marker (Figure 1).

Figure 1. Schematic of the lenti-vector used to generate the Cyno EpCAM Lentivirus.

Synonyms
Adenocarcinoma-associated antigen, Cell surface glycoprotein Trop-1, Epithelial cell surface antigen, Epithelial glycoprotein (EGP), Epithelial glycoprotein 314 (EGP314; hEGP314), GA733-2, M1S2, M4S1, MIC18, TACSTD1, TROP1
Product Info
Storage and Usage
Citations
Supplied As
Two vials (500 µl x 2) of lentivirus at a titer ≥107 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Formulation

The lentiviruses were produced in HEK293T cells in medium containing 90% DMEM + 10% FBS.  Virus particles can be packaged in custom formulations by special request, for an additional fee.

UniProt #
P16422
Background

EpCAM (Epithelial cell adhesion molecule), also known as CD90, is specific to epithelial cells and regulates cell proliferation and differentiation. It is used as an epithelial cell biomarker to detect circulating tumor cells. EpCAM belongs to the small GA733 protein family and is a homophilic transmembrane glycoprotein involved in cell-cell adhesion and tissue plasticity. It is a single-chain membrane-spanning protein with three major domains known as EpEX, involved in epidermal growth factor receptor (EGFR) mediated signaling pathways. Due to the versatile function of EpCAM and its crosstalk with other signaling pathways in cancer, EpCAM is considered an attractive target for cancer diagnosis, prognosis, and therapy.

References

Liu Y., et al., 2022, Exp Hematol Onco11: 97.